ZURA insider trading
NasdaqCM HealthcareZura Bio Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Zura Bio Ltd
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Company website: zurabio.com
ZURA insider activity at a glance
FilingIQ has scored 31 insider transactions for ZURA since Mar 20, 2023. The most recent filing in our index is dated Apr 1, 2026.
Across the full history, 7 open-market purchases
and 4 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ZURA insider trades is 58.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding ZURA
Frequently asked
- How many insider trades does FilingIQ track for ZURA?
- FilingIQ tracks 31 Form 4 insider transactions for ZURA (Zura Bio Ltd), covering filings from Mar 20, 2023 onwards. 8 of those were filed in the last 90 days.
- Are ZURA insiders net buyers or net sellers?
- Across the full Form 4 history for ZURA, 7 transactions (23%) were open-market purchases and 4 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ZURA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ZURA in?
- Zura Bio Ltd (ZURA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $641.39M.
Methodology & sources
Every ZURA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.